$0.961
-0.172 (-17.90%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Scienture Holdings Inc Stock?
TRxADE Health Inc is not a good buy right now due to its significant losses and declining performance. The current price is $0.96, which reflects a staggering year-to-date change of -72.71%. Additionally, the forward P/E ratio is 0, indicating no expected earnings growth, and the gross margin is a concerning -9.80% as of Q2 2026. The main risk is the company's negative net income, which reached -$18,363,225 in Q2 2026, highlighting ongoing financial instability.
MEDS stock price ended at $0.96 on Friday, after losing -17.90%
Scienture Holdings Inc (MEDS) last closed at $0.9606, losing -17.90%. These facts feed the 1-day and 1-week MEDS price prediction above.
Forecast Drivers
Scienture Holdings Inc (MEDS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
Seasonality analysis for MEDS
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.